GlassScriptPhysician profile
Casey Grillo
NPI 1801135942
$191,049.47
in general payments reported to CMS, 2019-2025
34 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18K · 2022: $49K · 2023: $52K · 2024: $34K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Travel and Lodging: $38K · Food and Beverage: $16K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $14K · Consulting Fee: $13K · Education: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,887.50 |
| Travel and Lodging | $38,184.11 |
| Food and Beverage | $16,093.05 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,556.26 |
| Consulting Fee | $13,490.42 |
| Education | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $153,306.67 | 2021-2025 | Proclaim, Eterna, Thoratec Heartmate 3 Lvas Implant Kit |
| Nalu Medical, INC. | $25,217.50 | 2021-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $1,897.83 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept Rf Probe, Intracept |
| Painteq LLC | $1,697.03 | 2021-2025 | Painteq |
| Spinal Simplicity, LLC | $1,170.99 | 2023-2025 | Ha Minuteman G3-R |
| Biohaven Pharmaceuticals, INC. | $917.65 | 2021 | |
| Vertos Medical, INC. | $783.35 | 2021-2024 | Mild Device Kit |
| Stryker Corporation | $770.84 | 2024-2025 | Mild Device Kit |
| Foundation Fusion Solutions, LLC | $728.93 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $553.30 | 2021-2025 | Xtampza |
| Relievant Medsystems, INC. | $450.64 | 2021-2023 | Intracept |
| Biotronik Nro, INC. | $418.64 | 2024-2025 | Prospera |
| Medtronic, INC. | $407.39 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $385.65 | 2021-2025 | Relistor |
| Saluda Medical Americas, INC. | $350.50 | 2022-2024 | Evoke, Evoke Scs |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $318.25 | 2022-2023 | Seglentis |
| Forte Bio-Pharma LLC | $272.38 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Pfizer INC. | $215.33 | 2023-2024 | |
| Spr Therapeutics, INC | $191.97 | 2022-2024 | Sprint Pns System |
| Mml US, INC. | $156.59 | 2025 | Reactiv8 |
| Scilex Pharmaceuticals INC. | $138.29 | 2025 | |
| Stimwave Technologies Incorporated | $116.99 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $104.23 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $83.81 | 2022 | |
| Almatica Pharma LLC | $82.95 | 2021-2022 | |
| Valinor Pharma, LLC | $56.94 | 2025 | Movantik |
| Grt US Holding, INC. | $49.74 | 2021-2022 | |
| Si-Bone, INC. | $48.11 | 2025 | |
| Averitas Pharma INC. | $45.89 | 2024-2025 | Qutenza |
| Biodelivery Sciences International, INC. | $33.83 | 2021 | |
| Abbvie INC. | $24.55 | 2022 | |
| Redhill Biopharma INC. | $19.56 | 2021 | |
| Ibsa Pharma INC. | $18.84 | 2025 | Tirosint, Licart, Flector |
| Bioventus LLC | $14.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Grillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.